Institutional Ownership Terns Pharmaceuticals, Inc. (TERN)
This table provides information about the institutional ownership of Terns Pharmaceuticals, Inc. (TERN). We have compiled data on the 134 institutions that hold shares in the stock, with a total of 84.3 Million shares, which have been reported (via 13F filing form) to have a value of $616 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
8,167,100
shares
|
$59.7 Million
2.36% of portfolio
|
Q1 2025
Added 0.3%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
7,562,971
shares
|
$55.3 Million
1.01% of portfolio
|
Q3 2024
Reduced 0.74%
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
7,495,000
shares
|
$54.8 Million
0.99% of portfolio
|
Q2 2025
Added 34.4%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
7,253,469
shares
|
$53 Million
0.0% of portfolio
|
Q2 2025
Added 2.02%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
6,895,746
shares
|
$50.4 Million
5.45% of portfolio
|
Q3 2024
Added 11.53%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
4,306,166
shares
|
$31.5 Million
0.0% of portfolio
|
Q2 2025
Added 3.71%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,120,508
shares
|
$30.1 Million
0.0% of portfolio
|
Q2 2024
Added 24.28%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
3,899,011
shares
|
$28.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.23%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
3,049,891
shares
|
$22.3 Million
0.09% of portfolio
|
Q2 2025
Reduced 20.68%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
2,633,918
shares
|
$19.3 Million
0.0% of portfolio
|
Q4 2024
Added 30.59%
|
|
Candriam S.C.A.
|
Aug 08, 2025 Q2 2025 |
2,368,235
shares
|
$17.3 Million
0.05% of portfolio
|
Q2 2025
Added 9.95%
|
|
Acorn Capital Advisors, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,971,264
shares
|
$14.4 Million
4.81% of portfolio
|
Q4 2024
New holding
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
1,650,950
shares
|
$12.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.24%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,633,349
shares
|
$11.9 Million
0.0% of portfolio
|
Q2 2025
Added 3.76%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,373,441
shares
|
$10 Million
0.0% of portfolio
|
Q2 2025
Added 3.69%
|
|
Superstring Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,286,681
shares
|
$9.41 Million
5.68% of portfolio
|
Q2 2025
Reduced 5.19%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,280,000
shares
|
$9.36 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
1,277,396
shares
|
$9.34 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
1,180,528
shares
|
$8.63 Million
0.0% of portfolio
|
Q2 2025
Reduced 16.03%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,171,619
shares
|
$8.56 Million
0.0% of portfolio
|
Q2 2025
Added 25.56%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
996,826
shares
|
$7.29 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.79%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
922,534
shares
|
$6.74 Million
0.0% of portfolio
|
Q2 2025
Reduced 35.66%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
817,808
shares
|
$5.98 Million
0.41% of portfolio
|
Q2 2025
Reduced 14.79%
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
714,285
shares
|
$5.22 Million
1.99% of portfolio
|
Q1 2022
New holding
|
|
Integral Health Asset Management, LLC
|
Aug 14, 2025 Q2 2025 |
700,000
shares
|
$5.12 Million
0.26% of portfolio
|
Q1 2025
Added 55.56%
|